Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6469512

COc1ccc2c(C)nc(Nc3nc(O)c4ccccc4n3)nc2c1OC.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.43
MAPT P10636 5/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MEN1 O00255 3/20 0.41
MAPK1 P28482 2/20 0.41
TP53 P04637 2/20 0.41
NPC1 O15118 2/20 0.41
ALDH1A1 P00352 2/20 0.41
RAB9A P51151 1/20 0.41
POLB P06746 6/20 0.39
LMNA P02545 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
HTT P42858 1/20 0.37
GAA P10253 2/20 0.36
TSHR P16473 1/20 0.36
RAD52 P43351 5/20 0.36
IGF1R P08069 1/20 0.35
SHMT2 P34897 1/20 0.35
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6470323 0.90 POLB (0.37) KMT2ASMN1; SMN2ALDH1A1POLBGAA
Trifluoroacetic Acid SCHEMBL6469409 0.86 KMT2A (0.43) KMT2AMAPTSMN1; SMN2MEN1MAPK1
Trifluoroacetic Acid SCHEMBL6470118 0.85 STAT3 (0.37) KMT2AMAPTSMN1; SMN2MEN1MAPK1
SCHEMBL6469516 0.85 KMT2A (0.42) KMT2AMAPTSMN1; SMN2MEN1MAPK1
Trifluoroacetic Acid SCHEMBL6470297 0.85 KMT2A (0.41) KMT2AMAPTSMN1; SMN2MEN1MAPK1
Trifluoroacetic Acid SCHEMBL6468690 0.83 ADORA2A (0.38) KMT2ASMN1; SMN2ALDH1A1POLBGAA
Trifluoroacetic Acid SCHEMBL6467880 0.83 HDAC3 (0.46) KMT2AMAPTSMN1; SMN2MEN1MAPK1
Trifluoroacetic Acid SCHEMBL6467878 0.82 KMT2A (0.47) KMT2AMAPTSMN1; SMN2MEN1MAPK1
Trifluoroacetic Acid SCHEMBL6470296 0.81 GAA (0.36) KMT2ASMN1; SMN2ALDH1A1POLBGAA
Trifluoroacetic Acid SCHEMBL6470311 0.81 TACR3 (0.37) KMT2AMAPTSMN1; SMN2MEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB KMT2A 2156/4885MAPT 3552/4885SMN1; SMN2 4360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.